Search - tctmd.com

Displaying 41 - 60 of 598

Sort: Relevancy | Date

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT Abstracts 2025

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Resurgence of Interest in the Role of Inflammation in HF

Presenter: Douglas Mann

February 11, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

News Daily News

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Yael L. Maxwell

January 17, 2025

News Daily News

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

Caitlin E. Cox

December 12, 2024

News Daily News

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

Todd Neale

December 11, 2024

News Conference News AHA 2024

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Caitlin E. Cox

November 21, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

L.A. McKeown

November 06, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

CON: Too Early or Too Risky

Presenter: Kevin Bainey

October 29, 2024

Presentation TCT 2024

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

Presenter: Vijay Kunadian

October 29, 2024

Presentation TCT 2024

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presenter: Deepak Bhatt

October 29, 2024

Advertisement

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Inflammation and HFpEF: Rationale for HERMES

Healthcare Professionals' Perspectives on the Treatment of Systemic Inflammation With Heart Failure and Associated Patient Journey Mapping

Resurgence of Interest in the Role of Inflammation in HF

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

CON: Too Early or Too Risky

PRO: Time is Now: Targeting Acute Inflammation and Residual Inflammatory Risk

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content